ERCC1 and glioma: For instance, high expression levels of the repair enzyme MGMT counteracts the effects of alkylating agents and predicts poor prognosis in gliomas.31 Conversely, low expression level of the DNA damage repair gene ERCC1 correlates with prolonged survival of patients with non-small cell lung cancer.32